Caracterización de pacientes hospitalizados con neoplasia activa y diagnóstico de enfermedad tromboembólica venosa mediante la puntuación de Khorana en el Instituto Nacional del Cáncer / Khorama score as a predictive tool for thromboembolic events in high risk patients
Rev. méd. Chile
; 144(5): 593-597, mayo 2016. ilus, tab
Article
in Spanish
| LILACS
| ID: lil-791046
Responsible library:
CL1.1
ABSTRACT
Background:
There is an established relation between cancer and the development of thromboembolic venous disease. Khorana et al developed a predictive score using clinical characteristics and laboratory values to stratify patients according to their risk.Aim:
To characterize using Khorana score, patients with active cancer and a diagnosis of thromboembolic disease during hospitalization in an oncology hospital. Material andMethods:
Review of records of the pharmacy of the hospital, selecting patients who received heparin in therapeutic doses during their hospitalization. Using laboratory values available in the medical records, the Khorama score was calculated.Results:
Twenty seven patients with thromboembolic events, aged 60 ± 2 years (56% males) were selected for the study. Eighty percent of them were catalogued in the intermediate and high risk group according to Khorana score.Conclusions:
Khorana score is a simple scale that might be useful to establish early prophylactic measures in patients with high risk for thromboembolic events, especially those with cancer.
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Venous Thromboembolism
/
Neoplasms
Type of study:
Diagnostic study
/
Etiology study
/
Prognostic study
/
Risk factors
Aspects:
Patient-preference
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2016
Document type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Instituto Nacional del Cáncer/CL